PROF.DR.BEULS
ActivePROF.DR.BEULS has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €149k and a net result of €29k. Equity is growing by ~26.6% per year across the filed fiscal years. Its solvency ranks better than 81% of 2152 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
90
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability90▼-10
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 8.13 against 7.38 in 2023; short-term debt: 11.9% and cash: 15.1% of total assets), and 11.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-07-2025, 14 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
14 d early
2023
15 d early
2022
29 d late
2021
25 d late
2020
58 d late
2019
18 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€149k▲ 24.3%
2023 · €120k
2018: €37k
2019: €54k
2020: €20k
2021: €52k
2022: €79k
2023: €120k
2018 → 2024
Total assets
€169k▲ 22.2%
2023 · €138k
2018: €113k
2019: €83k
2020: €82k
2021: €83k
2022: €111k
2023: €138k
2018 → 2024
Net result
€29k▼ 28.6%
2023 · €41k
2018: €41k
2019: €47k
2020: €9k
2021: €31k
2022: €27k
2023: €41k
2018 → 2024
Working capital
€144k▲ 21.4%
2023 · €118k
2018: €35k
2019: €53k
2020: €17k
2021: €50k
2022: €78k
2023: €118k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€20k-€52k▲ 153%€79k▲ 52.7%€120k▲ 51.5%€149k▲ 24.3%
Operating result€14k-€49k▲ 237%€41k▼ 15.3%€61k▲ 47.1%€37k▼ 38.5%
Net result€9k-€31k▲ 234%€27k▼ 12.7%€41k▲ 49.2%€29k▼ 28.6%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 38% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €169k
Fixed assets
€5k▲ 290%
Current assets
€164k▲ 19.7%
Equity and liabilities €169k
Equity
€149k▲ 24.3%
Debt
€20k▲ 8.7%
The debt ratio falls from 13.4% to 11.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€40k▼
2023 · €62k
Cash flow
€32k▼
2023 · €42k
Solvency
88.1%▲
2023 · 86.6%
Current ratio
8.13▲
2023 · 7.38
Quick ratio
8.13▲
2023 · 7.38
Debt / equity
0.14▼
2023 · 0.16
ROE
19.5%▼
2023 · 34.0%
ROA
17.2%▼
2023 · 29.4%
Interest coverage
74473.22▲
2023 · 343.44
Debt
€20k▲
2023 · €19k
Debt ≤ 1 year
€20k▲
2023 · €19k
Income taxes
€15k▼
2023 · €22k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€138k€169k▲
Fixed assets21/28€1k€5k▲
Tangible fixed assets22/27€1k€5k▲
Land and buildings22€0€0=
Plant, machinery and equipment23€0€0=
Furniture and vehicles24€1k€5k▲
Current assets29/58€137k€164k▲
Amounts receivable within one year40/41€71k€136k▲
Trade receivables40€6k€15k▲
Other amounts receivable41€66k€121k▲
Cash at bank and in hand54/58€65k€25k▼
Deferred charges and accrued income490/1€29€2k▲
Equity and liabilities
Total equity and liabilities10/49€138k€169k▲
Equity10/15€120k€149k▲
Contributions10/11€19k€19k=
Reserves13€101k€130k▲
Distributable reserves133€101k€130k▲
Amounts payable17/49€19k€20k▲
Amounts payable within one year42/48€19k€20k▲
Trade debts44-€7k
Suppliers440/4-€7k
Taxes, remuneration and social security45€19k€13k▼
Taxes450/3€19k€13k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€3k▲
Other operating charges640/8€881€953▲
Non-recurring operating charges66A€2k-
Gross operating margin9900€65k€41k▼
Operating profit (loss)9901€61k€37k▼
Financial income75/76B€2k€6k▲
Recurring financial income75€2k€6k▲
Financial charges65/66B€181€1▼
Recurring financial charges65€181€1▼
Profit (loss) for the period before taxes9903€63k€44k▼
Income taxes67/77€22k€15k▼
Profit (loss) for the period9904€41k€29k▼
Profit (loss) for the period to be appropriated9905€41k€29k▼
Appropriation of the result
Profit (loss) to be appropriated9906€41k€29k▼
Transfer to equity691/2€41k€29k▼
To other reserves6921€41k€29k▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
16-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Liquidity doublescurrent ratio 7.38
Current ratio from 3.43 to 7.38; short-term debt falls from €32k to €19k.
31-12
Financial
Equity above €100kEq €120k ▲51.5%
6 profitable years in a row build equity to €120k.
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 29 days late
2022
25-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 25 days late
2021
31-12
Financial
Liquidity doublescurrent ratio 2.61
Current ratio from 1.27 to 2.61; short-term debt falls from €61k to €31k.
27-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 58 days late
2020
31-12
Financial
Weakest financial yearnet €9k ▼80.2%
Net result drops to €9k, the lowest in the series; recovery starts the following year.
18-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 18 days late
2019
31-12
Financial
Highest result since 2018net €47k ▲14.9%
Operating result €69k, net result €47k, both a record.
31-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 31 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
2016
30-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2007
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Bonnefantenstraat 63500 HasseltGround area
5,900 m²
Building footprint
1,850 m²
Volume, LiDAR
19,962 m³
Parcel 71022H0054/00E000, Flanders · tallest building 24.0 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Prof.Dr.Beuls
since 20072.191.071.830
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71022H0054/00E000 | Flanders | 5,899 m² | 1 · 1,850 m² | 24.0 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Tim Decraecke, huisarts
BE 0665.553.028
Zwalm · Eq €149k
CliniCAP
BE 0790.915.927
Herzele · Eq €148k
DR. E. SCHREURS
BE 0459.653.108
Tremelo · Eq €148k
VDSlab
BE 0686.836.808
Les Bons Villers · Eq €151k
LC LAB
BE 0698.703.470
La Louvière · Eq €145k
Of 698 companies in sector 86910 we hold annual accounts for 520. 383 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-08-2007
Fiscal year end31-12
Activities, NACEBEL
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.